FOR TRANSLATIONAL RESEARCH IN NUCLEAR MEDICINE.
Arronax Nantes brings together all stakeholders in Nantes working on research and development in nuclear medicine.
This more particularly include the GIP ARRONAX, the laboratories Ceisam, CEMA-Oniris, CRCI2NA, LS2N, Subatech, the CRIP-Oniris core facility and the Nuclear Medicine departments of the University Hospital of Nantes and the ICO.
Arronax Nantes is a stakeholder in the I-SITE NExT, in close collaboration with the LabEx IRON and the SIRIC ILIAD.
our publications
Proton beam dosimetry at ultra-high dose rates (FLASH): Evaluation of GAFchromic™ (EBT3, EBT-XD) and OrthoChromic (OC-1) film performances, Villoing, D., Koumeir, C., Bongrand, A., Guertin, A., Haddad, F., Métivier, V., Poirier, F., Potiron, V., Servagent, N., Supiot, S., Delpon, G., Chiavassa, S, Medical Physics, 2022, 49 (4), 2732–2745
https://doi.org/10.1002/mp.15526211 At and 125 I‐Labeling of (Hetero)Aryliodonium Ylides: Astatine Wins Again, Maingueneau, C.; Berdal, M.; Eychenne, R.; Gaschet, J.; Chérel, M.; Gestin, J.; Guérard, F., Chemistry A European J 2022. doi:10.1002/chem.202104169
